Daniel N JR Swisher
CIK 1323113 · President and COO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.65M
Companies
6
Total Filings
112
Lifetime Open-Market Net
-$4.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | 2,200 | $82.91 | $182.4K | -$3.90M | 44 | 2026-05-26 |
| CERS | Director | 207,045 | $2.56 | $530.0K | -$280.0K | 28 | 2025-06-04 |
| PTGX | Director | — | $109.78 | — | $0 | 1 | 2023-10-30 |
| JAZZ | President and COO | 60,440 | $230.56 | $13.94M | $0 | 13 | 2023-03-07 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | President and CEO | 81,706 | $18.62 | $1.52M | $134.4K | 25 | 2017-07-12 |
| Viracta Therapeutics, Inc. (SNSSD) Delisted | President and CEO | 164,510 | — | — | $0 | 1 | 2011-03-02 |
Recent Filings · Page 8 of 12
112 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-07 | JAZZ | Tax (F) | −1,604 | -$202.1K | EDGAR |
| 2018-08-22 | CORT | Grant (A) | — | $0 | EDGAR |
| 2018-07-11 | CERS | Grant (A) | — | $0 | EDGAR |
| 2018-06-22 | CERS | Grant (A) | — | $0 | EDGAR |
| 2018-06-05 | CERS | Exer (M) | +19,816 | $0 | EDGAR |
| 2018-03-05 | JAZZ | Grant (A) | +18,000 | $0 | EDGAR |
| 2017-07-12 | Viracta Therapeutics, Inc. (SNSS) Delisted | Mixed | — | $0 | EDGAR |
| 2017-06-12 | CERS | Mixed | +12,336 | $0 | EDGAR |
| 2017-05-26 | CORT | Grant (A) | — | $0 | EDGAR |
| 2016-12-06 | Viracta Therapeutics, Inc. (SNSS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.